| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |